10q23.3 Loss of heterozygosity is higher in lymph node-positive (pT2-3, N+) versus lymph node-negative (pT2-3, N0) prostate cancer

Mark A. Rubin, Amy Gerstein, Kris Reid, David G. Bostwick, Liang Cheng, Ramon Parsons, Nickolas Papadopoulos

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of '10q23.3 Loss of heterozygosity is higher in lymph node-positive (pT2-3, N+) versus lymph node-negative (pT2-3, N0) prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences